Subscribe To
Verve Therapeutics to Participate in Upcoming Investor Conferences
BOSTON, Nov. 11, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in fireside chats during the following upcoming investor conferences: Jefferies London Healthcare Conference on […] The post Verve Therapeutics to Participate in Upcoming Investor Conferences...
Read More
Posted: Nov 11 2022, 11:30
Author Name: forextv
Views: 112516